thymoquinone has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, L; Duan, X; He, J; Ouyang, L; Shi, J; Wang, T; Zhang, H; Zhang, Y; Zhong, L; Zhu, Y | 1 |
| Ali, J; Baboota, S; Iqubal, A; Khan, SA; Nabi, B; Nehal, N; Parvez, S; Pathak, A; Rehman, S; Yar, MS | 1 |
| Clinton, CD; Hoq, MI; Ibrahim, M; Islam, MS; Jahan, I; Jakaria, M; Siddiqui, SA; Uddin, MN | 1 |
2 review(s) available for thymoquinone and Parkinson Disease
| Article | Year |
|---|---|
Recent advances in discovery and development of natural products as source for anti-Parkinson's disease lead compounds.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Drug Discovery; Humans; Molecular Structure; Parkinson Disease | 2017 |
The Mechanistic Role of Thymoquinone in Parkinson's Disease: Focus on Neuroprotection in Pre-Clinical Studies.
Topics: Benzoquinones; Humans; Neurodegenerative Diseases; Neuroprotection; Neuroprotective Agents; Parkinson Disease | 2021 |
1 other study(ies) available for thymoquinone and Parkinson Disease
| Article | Year |
|---|---|
Chitosan coated synergistically engineered nanoemulsion of Ropinirole and nigella oil in the management of Parkinson's disease: Formulation perspective and In vitro and In vivo assessment.
Topics: Animals; Benzoquinones; Chitosan; Disease Models, Animal; Drug Stability; Drug Synergism; Emulsions; Female; Humans; Indoles; Male; Molecular Docking Simulation; Nanoparticles; NF-kappa B; Nigella; Oxidopamine; Parkinson Disease; Plant Oils; Rats; Tumor Necrosis Factor-alpha | 2021 |